SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044024
Filing Date
2021-08-12
Accepted
2021-08-12 16:43:00
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alxo-10q_20210630.htm   iXBRL 10-Q 2847593
2 EX-31.1 alxo-ex311_8.htm EX-31.1 20846
3 EX-31.2 alxo-ex312_7.htm EX-31.2 20732
4 EX-32.1 alxo-ex321_6.htm EX-32.1 9458
5 EX-32.2 alxo-ex322_9.htm EX-32.2 9545
  Complete submission text file 0001564590-21-044024.txt   7561019

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alxo-20210630.xsd EX-101.SCH 49156
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxo-20210630_cal.xml EX-101.CAL 50896
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxo-20210630_def.xml EX-101.DEF 125842
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20210630_lab.xml EX-101.LAB 368711
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20210630_pre.xml EX-101.PRE 261966
11 EXTRACTED XBRL INSTANCE DOCUMENT alxo-10q_20210630_htm.xml XML 1095089
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39386 | Film No.: 211168279
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences